Timapiprant
N/A
Report date: 2023/08/02 20:00:51
NME
Base Information
Drug NameTimapiprant
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[7]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[10]
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesOxagen LtdAtopix Therapeutics Ltd
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesOxagen LtdAtopix Therapeutics LtdChiesi Farmaceutici SPA
Active IndicationsN/A
Inactive Indications +[7]
Other Information
ATC CodeN/A
Related LinksN/A